Clinical implications of fatty pancreas: Correlations between fatty pancreas and metabolic syndrome

Table 2 Multivariate logistic regression analysis for the fatty pancreas

Model		Odds ratio (95% CI)	P-value
Model 1	Age (yr)	1.025 (0.999-1.051)	0.059
	Sex (male/female)	0.397 (1.474-4.311)	0.001
	Fasting glucose (mg/dL)	0.998 (0.987-1.010)	0.747
	HOMA-IR	2.319 (1.431-3.757)	0.001
Model 2	Model 1
	(HOMA-IR)	1.761 (1.041-2.978)	0.035
	+
	TC (mg/dL)	1.005 (0.998-1.013)	0.184
	TG (mg/dL)	1.004 (1.000-1.008)	0.060
	FFA (mg/dL)	1.000 (0.999-1.001)	0.409
Model 3	Model 2
	(HOMA-IR)	0.990 (0.533-1.839)	0.973
	+
	BMI (kg/m2)	1.137 (0.965-1.339)	0.125
	Visceral fat	1.000 (1.000-1.000)	0.006
	Subcutaneous fat	1.000 (1.000-1.000)	0.932
	Thigh fat	1.000 (1.000-1.000)	0.214

Model 1: HOMA-IR and fasting glucose were adjusted for age, sex; Model 2: In addition to Model I, HOMA-IR and fasting glucose were adjusted for lipid profiles (TC, TG, FFA); Model 3: In addition to Model II, HOMA-IR and fasting glucose were adjusted for BMI and fat distribution factors (abdominal visceral fat area, abdominal subcutaneous fat area, thigh fat area). P < 0.05 was considered to be significant throughout the analysis.